United States: Going To 11: New Subsections At CDER's Office Of Pharmaceutical Quality Are Important Piece Of FDA's Inspection And Enforcement Strategy - Hyman, Phelps, & McNamara, P.C.

United States: Going To 11: New Subsections At CDER's Office Of Pharmaceutical Quality Are Important Piece Of FDA's Inspection And Enforcement Strategy - Hyman, Phelps, & McNamara, P.C.

Mondaq

Published

The word last week was that FDA is re-organizing the Office of Pharmaceutical Quality (OPQ) within the Center for Drug Evaluation and Research (CDER).

Full Article